Toolika Agrawal, Ph.D.
Toolika Agrawal, Ph.D. received a Master’s degree from University of Mumbai, India in 2008. She then joined Nycomed Pharma, Mumbai where she was involved in synthesis of compound libraries for drug discovery. In 2015 she completed her Ph.D. under the guidance of Prof. Silas Cook at Indiana University, Bloomington. There she was involved in new methodology development involving use of iron catalysts. Post Ph.D. she worked at Syngenta where she was involved in early stage route scouting and route optimisation towards various agrochemical candidates. In January 2020, she joined Prof. Joshua Sieber’s group at VCU where she is involved in transition metal catalysis for the development of new synthetic methods. Another focus of her research is the development of cost-effective strategies for the synthesis of a tuberculosis drug in partnership with Medicines for All Institute at the VCU Engineering department.
Juliana de Souza, Ph.D.
Juliana de Souza attended the Federal University of São Carlos (UFSCar, Brazil) where she received a B.S. in Technological Chemistry in 2013. She continued at UFSCar and obtained her Master's degree in Organic Chemistry in 2016, exploring the synthesis of porphyrin derivatives synthesizers with potential application in Photodynamic Therapy (PDT). She completed her doctorate in Organic Chemistry in early 2020 at UFSCar under the guidance of Dr. Kleber T. de Oliveira. There, her main focus was photochemical reactions under continuous flow conditions. During her Ph.D. program she left Brazil to participate in a student exchange program and joined Dr. Tyler McQuade’s group at the Medicines for All Institute (M4ALL) at VCU in 2018. She worked with Process Chemistry and the synthesis of APIs for the production of HIV/AIDS drugs. Currently, she is a postdoctoral researcher associate in Dr. Snead’s laboratory at M4ALL.
Renan S. Galaverna, Ph.D.
Renan S. Galaverna, Ph.D. obtained his MChem degree from the University of Campinas (UNICAMP) followed by his Ph.D. under the guidance of Dr. Julio C. Pastre in 2019. Afterwards, he was a visiting student at Cardiff University under Dr. Duncan L. Browne for one year. As a postdoctoral research associate for Dr. Pastre’s lab, Dr. Galaverna served in a team lead role managing students in their projects. His main research interests include the application of Continuous Flow Process and Design of Experiments (DoE) for the development of new methodologies in organic synthesis, synthesis of biomass-based compounds as well as new strategies for drug synthesis.
Appasaheb Kadam, Ph.D.
Appasaheb Kadam received his Ph.D from CSIR-National Chemical Laboratory, Pune, India, under the supervision of Dr. Subhash P. Chavan. He worked on total synthesis of natural products and was involved in several process development projects towards various drug and agrochemical candidates. Dr. Kadam also worked as a junior research scientist at Syngenta, Goa and contributed in process optimization and large scale synthesis towards various agrochemical candidates. He joined as a postdoctoral research associate for Medicines for All in October 2020 and is working on drug discovery and process development to access active pharmaceutical ingredients (APIs).
Hanuman Kalmode, Ph.D.
Dr. Hanuman Kalmode earned his PhD in 2015 from the Institute of Chemical Technology in Mumbai, India. Hi dissertation studied the development of novel method for the functionalized chiral carbocycles, heterocycles and imides. After graduation he joined the CSIR-National Chemical Laboratory in Pune, India as a National Post-Doctoral Fellow (N-PDF) and worked with Dr. D. Srinivasa Reddy on the method development and synthesis of sesquiterpenoids based Natural Products.
Most recently, Dr. Kalmode has been participating in his second postdoctoral experience working under Dr. John Bushweller at the University of Virginia. With UVA, he synthesized inhibitors of the transcription factor fusion protein MLL-AF9 as well as other transcription factor targets. Dr. Kalmode also brings experience working at Chembiotek Research International in Pune, India where he was contracted to synthesize target molecules for multinational companies such as Merck, Pfizer, GSK, Carna Biosciences, RedPoint Bio etc.
Pankaj Khairnar, Ph.D.
Dr. Pankaj Khairnar is a postdoctoral fellow at Medicines for All Institute (M4ALL) working on the low-cost synthesis and process development to access active pharmaceutical ingredients (APIs). He received his Ph.D in 2020 from National Taiwan Normal University, Taipei, Taiwan, under the supervision of Prof. Wenwei Lin, where he worked on asymmetric organocatalysis and intramolecular Wittig reactions strategy using nucleophilic phosphine. Before his Ph.D he worked as an project assistant (2014-2016) at CSIR-National Chemical Laboratory, Pune, India, under the supervision of Dr. D. Srinivasa Reddy, where he worked on total synthesis of natural products and was involved in several medicinal chemistry programs.
Sanjay Maity, Ph.D.
Sanjay Maity completed his Ph.D. in 2018 from Indian Institute of Science Education and Research Bhopal, India under the supervision of Prof. Prasanta Ghorai. During his Ph.D., he worked on Organocatalytic Enantio and Diastereoselective synthesis of Oxa and Carbocycle. Later in June 2018, he joined as a postdoctoral research associate in Dr Joseph J. Topczewski group, University of Minnesota, USA. There he worked on Alkene-Azide Rearrangement. In June 2019 he moved to Professor Mark D. Distefano group, University of Minnesota for his second postdoctoral research. There he worked on the synthesis of water-soluble isoprenoid diphosphate for metabolic labeling. He is currently working with Medicines for All Institute (M4ALL) as a postdoctoral fellow on the low-cost synthesis and process development to access active pharmaceutical ingredients (APIs).
Yuma is a graduate student in Chemical and Life Science Engineering working under the guidance of Dr. Thomas Roper. His research focus is process development for continuous manufacturing of active pharmaceutical ingredients (APIs) coupled with process analytical technology (PAT) and process control.
Roudabeh Moazeni, Ph.D.
Roudabeh Moazeni obtained her Ph.D. in Chemometrics, Analytical Chemistry at Sharif University of Technology, Tehran, Iran, in 2014. Her research focuses on the application of mathematical and statistical methods to evaluate data and analytical measurements. Dr. Moazeni combines chemometrics and analytical chemistry for use in areas such as biology, pharmaceuticals, chemistry, chemical engineering, food and environmental sciences. Her slogan is to “Help and make the people of the world be healthier and happier”. She joined Medicines for All Institute at VCU to develop process analytical technologies and chemometric models which can monitor the quality of pharmaceutical processes.
Jeffrey Noble is a graduate student in VCU’s Chemistry Department. He attended the University of Richmond where he received a B.S. in biochemistry and molecular biology. Jeffrey currently works with the Gupton Lab.
Ravi Kumar Ongolu, Ph.D.
Ravi Kumar Ongolu Ph.D., is a postdoctoral fellow at Medicines for All Institute (M4ALL) working on the synthesis of active pharmaceutical ingredients using the principles of green chemistry in batch and continuous flow operations. Before joining M4ALL, he worked as a postdoctoral fellow in Dr. Umesh R. Desai’s laboratory at VCU where he synthesized glycosaminoglycan mimetics, lipid-modified analogs of a sulfated flavonoids and photoaffinity probes for the identification of protein targets. He holds a Ph.D. in organic chemistry from IIT Bombay, India under the supervision of Prof. S. Kotha. His thesis work focused on Ru-catalyzed ring-rearrangement metathesis for the synthesis of complex carbo- and heterocyclic compounds. He also worked at Laurus Labs, Hyderabad, India, there he gained experience in process R&D and scale up process.
Dinesh Paymode, Ph.D.
Dinesh J. Paymode, Ph.D., received his bachelor’s and master’s degree from University of Pune, Pune, India. In 2012, he associated with Dr. C. V. Ramana research group at CSIR–National Chemical Laboratory, Pune for his doctoral studies. During his Ph.D., he worked on total synthesis of allocolchicine, parvifolal A/B and Ru–catalyzed C–H activation. Later, in 2018, he joined Dr. Sharma’s lab as a postdoctoral fellow at University of Oklahoma, where he focused on Rh-carbenoid initiated cascades for the synthesis of diverse heterocycles. Currently, he is a postdoctoral fellow in Dr. Gupton’s laboratory and Medicines for All. He is working on drug discovery and process development to access active pharmaceutical ingredients (APIs).
Brijesh Sharma, Ph.D.
Brijesh Sharma, received his Ph.D. in 2018 from CSIR-National Chemical Laboratory, Pune, India, under the supervision of Dr. Pradeep Kumar. During his Ph.D. he worked on total synthesis of natural products and development of C-C bond forming methodologies. Later, in June 2018 he joined the group of Dr. Amol Kulkarni, CSIR-NCL, Pune, India, where he worked on handling solids in continuous flow along with development of continuous flow process for CDCl3. In July 2019, he joined Prof. Kim's lab in POSTECH, South Korea, where he focused on developing one-flow neutralization of organophosphonate derived pesticide/nerve agent simulant using 3D-printed PTFE, development of cyanation protocol and flow parallel synthesizer as a screening platform. He is currently working with Medicines for All as a postdoctoral research associate on improving cost effective and efficient processes to access active pharmaceutical ingredients (APIs) in flow.
Vidyacharan Sinde, Ph.D.
Vidyacharan Sinde completed his Ph.D. in 2016 under the guidance of Dr. D. S. Sharada at Indian Institute of Technology Hyderabad, India. During his Ph.D., he worked on development of sustainable and C-H activation strategies for the synthesis of novel and bioactive heterocyclic scaffolds. He worked as a research scientist at Intonation research lab Hyderabad, India, There he worked on synthesis of key precursors for drug scaffolds. He joined Prof. Dong-Pyo Kim's research group in 2017 as a post-doctoral research associate at Pohang University of Science and Technology, South Korea where he focused on photoredox catalysis, ultra-fast reactions for the synthesis of bioactive scaffolds using continuous flow platform. He is currently with Medicines for All working on continuous-flow process development to access active pharmaceutical ingredients (APIs).
John Tomlin graduated from William and Mary in 2015 with his B.S. in Chemistry. Since then he has worked in industry at M.W. Environmental Services. Currently he is a graduate student at Virginia Commonwealth University and works in Dr. Gupton's lab